PERMIDES is one out of five European INNOSUP-1-2015 – Cluster facilitated projects for new value chains projects (funded under EC Call for proposal: H2020-INNOSUP-2015-1).
It is the aim of PERMIDES to strengthen the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Industry in Europe by providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology (i.e. cancer treatment). Current value chain challenges lie in e.g. data gathering and exchange, big data and machine learning, or new software-based marketing methods based.
Via a cross-clustering approach, leading biopharma and IT clusters from three countries (Austria, Germany and
Norway) will create novel cross-sectoral collaborations between SMEs to address innovation barriers in the biopharma sector via cutting-edge IT solutions. As a cross-cutting industry, the ICT and software sector is an enabler of innovation in many industries and therefore provides a broad knowledge base of processes and best practice solutions in diverse industrial contexts and business environments.
Download PERMIDES Strategy Document D1.3
“We are very satisfied with the platform and already started discussion with one company for a collaboration on a mutually interesting and very innovative project.” Marco Roccato, MediSapiens; Finland